# OXALIPLATIN
> **ANDA204880** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS · Approved 2018-03-05
## Drug
- **FDA Application Number:** ANDA204880
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXALIPLATIN
- **Generic name:** Oxaliplatin
- **Active ingredients:** OXALIPLATIN
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS
- **First approval:** 2018-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204880)
---
*MORVS · CC0 1.0*